ROCHESTER, N.Y., April 27 /PRNewswire-FirstCall/ -- VirtualScopics, Inc. , a leading developer of image-related biomarker solutions, announced today the appointment of Jeffrey Markin as the chief operating officer. Markin is leaving the Eastman Kodak Company after 26 years of service to join the VirtualScopics executive team. He will be responsible for the overall operations of the company.
“We are extremely fortunate to have attracted an executive with the skill and experience of Markin,” said Bob Klimasewski, president and CEO of VirtualScopics. “With his proven track record at Kodak, we are confident he will be able to continue VirtualScopics’ progress into the larger markets.”
Markin’s most recent post was in the health group at Kodak as vice president and general manager of output systems and mammography solutions. Since joining the health group in 2001, he has managed major group operations including leadership of the conventional x-ray business, mammography solutions, healthcare IT software and solutions business, and global radiology sales and service organization.
Previously, Markin held leadership positions in the document imaging business, including vice president of North American marketing, global general manager of the output business and general manager of the Asian-based services business with operations in China, Hong Kong, Philippines, Malaysia and Australia. He also served on the board of directors for Hermes Precisa Australia, the leading document services company in Australia.
He joined Kodak as a manufacturing engineer in the company’s Rochester, N.Y. film operations division and subsequently held technical management positions in manufacturing, research and development and quality at both the Rochester and Toronto, Canada facilities.
Markin is a Six Sigma Management Black Belt and in 2004 he won the Kodak Chairman’s leadership award for his inspired management of company and health group business imperatives. He has a bachelor of science degree in industrial engineering from State University of New York at Buffalo and an executive master of business administration from the Simon School of Business at the University of Rochester.
“With blue-chip clients such as Pfizer and GlaxoSmithKline, VirtualScopics has a robust foundation on which to continue building a world class biotechnology company,” said Markin. “I look forward to working closely with them and the management team to accelerate its growth.”
About VirtualScopics, Inc.
VirtualScopics, Inc. is a provider of advanced medical image analysis services. The company evolved from research first carried out at the University of Rochester Medical Center and School of Engineering. VirtualScopics has created a suite of image analysis tools used in detecting and analyzing specific structures in volumetric medical images, as well as characterizing minute changes in structures over time, providing vital information to support clinical trials and diagnostic applications. The firm’s proprietary software algorithms can assemble hundreds of separate medical images taken during an MRI session into a single, three-dimensional model, bringing a new and previously unobtainable source of data to clinical researchers. For more information about VirtualScopics, visit http://www.virtualscopics.com.
Forward-Looking Statements
The statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbors created thereby. Forward-looking statements deal with the Company’s current plans, intentions, beliefs and expectations. Investors are cautioned that all forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed from time to time in reports filed by the Company with the Securities and Exchange Commission.
CONTACT: Tracy Bagatelle-Black Bagatelle-Black Public Relations 661/263-1842 tracy@bagatelleblack.com
VirtualScopics, Inc.
CONTACT: Tracy Bagatelle-Black of Bagatelle-Black Public Relations forVirtualScopics, Inc., +1-661-263-1842, tracy@bagatelleblack.com
Web site: http://www.virtualscopics.com/
